Category: Sleep & Calm

Published July 20, 2026

L-theanine shows up in a lot of “focus” and “calm” supplement blends, usually paired with caffeine. The pitch is simple: a compound found naturally in tea leaves that supposedly smooths out jitteriness while keeping you alert. That is a specific, testable claim, and it turns out researchers have actually tested versions of it. This article walks through what the human studies looked at, what they found, where the evidence is thinner than the marketing suggests, and what a reasonable, cautious take on L-theanine looks like.

What L-theanine actually is

L-theanine is an amino acid found almost exclusively in tea plants (Camellia sinensis) and a few mushroom species. It’s part of why tea “feels” different from coffee even when both contain caffeine — tea leaves naturally deliver a small dose of theanine alongside the caffeine. Isolated L-theanine supplements typically use doses far higher than what you’d get from a single cup of tea, which is one reason researchers study the purified compound directly rather than relying on tea-drinking observations alone.

Mechanistically, L-theanine crosses the blood-brain barrier and appears to influence alpha brain wave activity and several neurotransmitter systems, including glutamate, GABA, dopamine, and serotonin pathways. Alpha waves are associated with a state of relaxed wakefulness — not drowsy, not tense. That’s the physiological hook researchers have used to explain why theanine might produce a “calm but alert” subjective effect, but a plausible mechanism is not the same thing as a proven outcome, so it’s worth looking at what the actual trials measured.

The foundational alpha-wave study

One of the most-cited early studies is Nobre, Rao, and Owen (2008), published in the Asia Pacific Journal of Clinical Nutrition, which reviewed EEG (electroencephalogram) research showing that L-theanine increases alpha wave activity in the brain, particularly at doses in the 50–200 mg range. Alpha wave increases are generally interpreted as a marker of relaxation without sedation. This is useful groundwork, but EEG changes are a biomarker, not a lived outcome — the more relevant question is whether people actually perform or feel differently.

Theanine plus caffeine: the combination studies

The most consistently cited human trial here is Kelly, Gwartney, and Sanders’ work along with the earlier Haskell et al. and Owen et al. studies on the L-theanine/caffeine combination, but the one most commonly referenced by name is Kelly SP et al. (2008), “L-theanine and caffeine in combination affect human cognition as evidenced by oscillatory alpha-band activity and attention task performance,” published in the Journal of Nutrition. This study looked at attention-switching tasks and found that the combination of caffeine and L-theanine — not either compound alone — was associated with improved accuracy during attention-switching tasks and reduced susceptibility to distracting information, compared with placebo.

That “combination, not either alone” detail matters. Several of the positive human-performance findings for theanine come specifically from caffeine-plus-theanine protocols, not L-theanine given by itself. If you’re evaluating a theanine-only product for focus, it’s worth knowing that some of the strongest cognitive-performance evidence was for a stack, not the isolated ingredient.

A 2019 meta-analysis on attention and reaction time

Kahathuduwa et al. (2020), published in Nutrition Reviews (“Acute effects of theanine, caffeine and theanine-caffeine combination on attention”), pooled data across multiple randomized trials. The meta-analysis reported that the caffeine-theanine combination was associated with faster reaction times and improved accuracy on attention-switching tasks relative to placebo, while L-theanine alone showed more modest and less consistent effects on these particular attention measures. This is a more rigorous way to weigh the evidence than any single trial, and it lines up with the caveat above: the attention-and-reaction-time story is strongest when theanine is combined with caffeine.

Stress and anxiety-adjacent measures

Separately from cognitive performance, some trials have looked at self-reported stress and anxiety symptoms. Hidese et al. (2019), published in Nutrients, ran a randomized, double-blind, placebo-controlled trial in adults with subclinical symptoms of depression and anxiety, using 200 mg/day of L-theanine over several weeks. The study reported improvements in several self-reported measures, including sleep quality and certain anxiety- and depression-related symptom scores, compared to placebo. This is a legitimate peer-reviewed trial, but it’s worth being precise about its limits: it was a relatively small study population, it measured subjective symptom scales (not a clinical diagnosis outcome), and it should not be read as evidence that L-theanine treats anxiety or depression as medical conditions. “May support a sense of calm” is a fair summary of this kind of data; “treats anxiety” is not, and no reputable reading of this literature supports a disease-treatment claim.

Older, smaller studies — including some using acute stress-induction tasks in healthy volunteers — have reported reductions in physiological stress markers (like salivary cortisol or heart rate variability changes) after single doses of L-theanine. These acute-stress-response findings are interesting but come from small samples and short-term designs, and results have not been uniformly replicated across every follow-up trial, which is common in this area of nutrition research and is a reason to hold the findings a bit loosely rather than treat them as settled.

What the National Institutes of Health resources say

The NIH Office of Dietary Supplements does not maintain a standalone consumer fact sheet specifically for L-theanine the way it does for better-established nutrients like magnesium or vitamin D, which itself is a signal that the evidence base, while real, is still developing rather than settled. General overviews from NIH-affiliated and academic sources describe L-theanine as generally well-tolerated in the dose ranges used in research (commonly 100–400 mg/day, often split into two doses), with reported research-context side effects being mild and infrequent — headache and mild gastrointestinal upset in some sensitive individuals being the most commonly noted.

Typical doses used in research

Across the trials above, researchers have generally used:

• 50–200 mg for EEG/alpha-wave studies
• ~100–200 mg combined with caffeine (often 50–100 mg caffeine) for attention/cognitive-performance studies
• 200 mg/day, sometimes for several weeks, for the stress/mood-adjacent self-report studies

This is a useful reference range for understanding what’s actually been studied — it is not a personalized dosing recommendation, and you should not treat it as one.

Honest limitations of this evidence base

A few things are worth being upfront about:

• Sample sizes are often small. Many of the human trials involve a few dozen participants, not thousands. That’s normal for nutrition science but means individual results should be interpreted cautiously and replication matters.
• Effects are often modest and combination-dependent. Some of the clearest cognitive-performance findings involve theanine paired with caffeine, not theanine alone.
• Subjective outcomes are, well, subjective. Self-reported calm or reduced stress is a real and meaningful outcome to study, but it’s more susceptible to placebo response than an objective lab measure.
• L-theanine is not a treatment for any diagnosed medical or mental health condition. Nothing in this research supports using it to treat anxiety disorders, depression, ADHD, or any other diagnosis. If you’re dealing with a clinical condition, that’s a conversation for a licensed clinician, not a supplement label.

Who might reasonably consider it, and who should be cautious

People curious about a gentler, non-sedating way to take the edge off caffeine, or who want to explore whether a tea-derived compound helps them feel calmer without feeling foggy, are the population most of this research speaks to. It is not a fit for everyone: pregnant or breastfeeding people, anyone on medication for blood pressure or psychiatric conditions, and anyone with an existing diagnosed anxiety or mood disorder should talk to a doctor before adding any new supplement, since interactions and appropriate dosing in those situations haven’t been well studied.

The bottom line

The research on L-theanine is real, peer-reviewed, and points in a consistent direction: it may support a calmer, more relaxed state of alertness, with the best cognitive-performance evidence showing up when it’s combined with a modest amount of caffeine. It is not a cure, not a guaranteed fix for stress or focus problems, and the evidence base — while legitimate — is still smaller and less definitive than headlines sometimes suggest. Anyone considering it should treat it the way the research actually supports: as one small, well-tolerated input among many (sleep, exercise, workload, caffeine intake) rather than a stand-alone solution.

If you want to see where L-theanine fits into a broader supplement lineup, NutriPeak’s focus and calm formulation lists its L-theanine content directly on the label, so you can compare it against the dose ranges discussed in the research above and decide what makes sense for you.

This article is for informational purposes only and is not medical advice. It does not diagnose, treat, cure, or prevent any disease. Talk to a healthcare provider before starting any new supplement, especially if you are pregnant, nursing, taking medication, or managing a diagnosed health condition.

Sources: Nobre AC, Rao A, Owen GN. “L-theanine, a natural constituent in tea, and its effect on mental state.” Asia Pac J Clin Nutr 2008. Kelly SP et al. “L-theanine and caffeine in combination affect human cognition.” J Nutr 2008. Kahathuduwa CN et al. “Acute effects of theanine, caffeine and theanine-caffeine combination on attention.” Nutr Rev 2020. Hidese S et al. “Effects of L-Theanine Administration on Stress-Related Symptoms and Cognitive Functions in Healthy Adults.” Nutrients 2019. NIH Office of Dietary Supplements, general fact sheet resources.

Last updated: July 20, 2026

Ashwagandha (Withania somnifera) is one of the most-studied adaptogenic herbs on the supplement market, and KSM-66 is the specific, standardized root extract used in a majority of the modern human trials. This article walks through what the actual published research says about KSM-66 and stress-related markers like self-reported stress, anxiety symptoms, sleep, and serum cortisol — along with the limits of that research and who should be cautious. Nothing here is a claim that ashwagandha treats, cures, or prevents any disease; the language below intentionally stays in “may support” territory because that is what the evidence base currently allows.

What is KSM-66?

KSM-66 is a trademarked, full-spectrum root-only extract of ashwagandha, standardized to a defined withanolide content and produced without the use of alcohol in extraction. It is one of the more heavily researched proprietary ashwagandha extracts, which matters because “ashwagandha” as a category covers many different extraction methods, plant parts (root vs. leaf vs. root+leaf), and withanolide concentrations — results from one extract don’t automatically transfer to another. When you’re comparing studies, checking whether the study used KSM-66 specifically (versus a generic or different branded extract) is a meaningful detail, not a technicality.

The core human trials

Chandrasekhar et al., 2012 (Indian Journal of Psychological Medicine, PMID 23439798). This is the most frequently cited KSM-66 trial. It was a randomized, double-blind, placebo-controlled study in 64 adults with a history of chronic stress, given either 300 mg of high-concentration full-spectrum ashwagandha root extract twice daily or placebo for 60 days. The ashwagandha group showed significantly greater reductions on the Perceived Stress Scale (PSS) and other stress and anxiety questionnaires compared to placebo, and serum cortisol levels were reduced by roughly 27.9% in the treatment group versus a much smaller change in placebo. This is a reasonably solid early trial, but the sample size is modest and it is a single study from one research group.

Lopresti, Smith, Malvi & Kodgule, 2019 (Medicine (Baltimore), PMID 31517876). A 60-day randomized, double-blind, placebo-controlled trial in 60 adults with self-reported high stress, comparing 240 mg/day of a standardized ashwagandha extract to placebo. The treatment group showed significant improvements in self-reported stress and anxiety scores, sleep quality, and food cravings, along with a significant reduction in morning serum cortisol relative to placebo. This trial also measured DHEA-S and testosterone changes, which is a reminder that ashwagandha’s studied effects extend beyond stress markers alone — another reason to talk to a doctor before combining it with hormone-related medications or conditions.

Salve, Pate, Debnath & Langade, 2019 (Cureus, PMID 31728244). A double-blind, randomized, placebo-controlled study in 60 healthy adults given 300 mg of ashwagandha root extract twice daily for 8 weeks. Researchers reported significant improvements in stress-related outcome measures (including PSS and other stress/anxiety scales) and improved sleep quality scores in the treatment group compared to placebo, with good tolerability.

Auddy et al., 2008 (Journal of the American Nutraceutical Association). An earlier, smaller placebo-controlled study reporting reductions in serum cortisol and improvements in stress-related symptom scores over 60 days of ashwagandha extract supplementation in chronically stressed adults. It is frequently cited as early supporting evidence but predates the larger, better-designed trials above.

What this body of evidence adds up to — and doesn’t

Taken together, these trials consistently point in the same direction: in adults reporting chronic or elevated stress, 8–12 weeks of standardized ashwagandha root extract supplementation is associated with lower self-reported stress and anxiety scores and, in several trials, measurably lower serum cortisol compared to placebo. That consistency across multiple independent research groups is meaningfully more convincing than any single trial on its own.

That said, honest limitations matter:

• Sample sizes are small. Most of these trials involve 60–64 participants — enough to detect a signal, not enough to rule out variability across different populations.
• Trial duration is short. Most studies run 8–12 weeks. We don’t have strong long-term (6-12 month+) data on sustained use.
• Populations are narrow. Many trials specifically recruited adults who self-identified as having chronic stress, which is not the same as the general population, and results may not generalize to everyone.
• Funding and author overlap. A number of the KSM-66-branded trials involve authors and funding connected to the extract’s manufacturer, which doesn’t invalidate the data but is a relevant disclosure to weigh, per standard practice recommended by NIH NCCIH when evaluating supplement research.
• Cortisol is one biomarker, not a diagnosis. A change in serum cortisol under controlled trial conditions is not the same as treating a stress disorder, adrenal condition, or any diagnosed illness.

For a plain-language overview from a federal source, the NIH’s National Center for Complementary and Integrative Health maintains a fact sheet on ashwagandha’s studied uses, dosing ranges seen in research, and safety considerations — a useful starting point alongside the primary trials above.

Sleep and mood: a related but separate body of research

Several of the same research groups that studied ashwagandha for stress have also published double-blind, placebo-controlled trials specifically on sleep quality (for example, Langade et al., Cureus, on ashwagandha root extract in adults with insomnia and anxiety), generally finding improvements in subjective sleep quality and sleep onset latency versus placebo over several weeks. Stress and sleep are physiologically intertwined, so it’s not surprising the same extract shows effects in both areas — but sleep-specific claims should rest on the sleep-specific trials, not be inferred loosely from the stress trials alone.

Cautions

Ashwagandha is generally well tolerated in the published trials at studied doses (commonly 240–600 mg/day of standardized extract), with the most frequently reported side effects being mild gastrointestinal upset or drowsiness. But there are real reasons for caution, and this is not a complete medical list:

• Thyroid conditions:
• Pregnancy and breastfeeding: ashwagandha is traditionally contraindicated in pregnancy in some sources, and there isn’t robust modern safety data for pregnant or breastfeeding people. Avoid unless a physician advises otherwise.
• Autoimmune conditions: because ashwagandha may modulate immune activity, people with autoimmune diseases (e.g., rheumatoid arthritis, lupus, Hashimoto’s) should consult a doctor first.
• Liver health: there are published case reports of liver injury temporally associated with ashwagandha use, and some regulatory bodies (including health authorities outside the US) have flagged this as a signal worth monitoring. Anyone with existing liver disease, or who develops symptoms like jaundice, dark urine, or unusual fatigue while taking it, should stop and see a doctor.
• Sedatives and blood pressure/thyroid/immunosuppressant medications: ashwagandha may interact with these drug classes; check with a pharmacist or physician before combining.
• Surgery: because of possible sedative and immune effects, it’s commonly recommended to stop ashwagandha at least two weeks before scheduled surgery.
• Not a substitute for care: ashwagandha research measures statistical changes in group averages under trial conditions. It is not a treatment for clinical anxiety, depression, or endocrine disorders, and nothing here should replace evaluation by a licensed clinician for those conditions.

As always, quality and dose matter — look for a product that states the specific extract (e.g., KSM-66) and the standardized withanolide content, rather than a generic “ashwagandha” label with no extraction or standardization details.

The bottom line

Multiple independent, randomized, placebo-controlled human trials — Chandrasekhar 2012, Lopresti 2019, Salve 2019, and earlier work by Auddy — consistently report that standardized ashwagandha root extract supplementation over 8–12 weeks is associated with lower self-reported stress and anxiety scores, and in several trials, reduced serum cortisol, compared to placebo. This is genuinely one of the better-supported adaptogen categories in the supplement world, but the trials are still relatively few, small, and short-term, so “may support a healthy stress response” is the honest framing — not a guarantee, and not a substitute for medical care when stress, anxiety, or sleep problems are significant or persistent.

If you want to try a standardized extract for yourself, NutriPeak carries a KSM-66 ashwagandha formula dosed in the range studied in the trials above — worth a look if you’re deciding what to check the label for regardless of where you buy.

This article is for educational purposes and is not medical advice. Talk to a healthcare provider before starting any supplement, especially if you are pregnant, nursing, managing a chronic condition, or taking medication.

Magnesium Glycinate for Sleep and Stress: What the Evidence Actually Shows

Published 2026-07-20

If you’ve spent any time browsing sleep or stress-support supplements, you’ve probably run into magnesium glycinate. It’s one of the most talked-about forms of magnesium, and for good reason: it combines a mineral involved in hundreds of body processes with an amino acid (glycine) that has its own calming reputation. But what does the actual research say, and who is this combination realistically for? This article walks through what magnesium glycinate is, what the evidence does and doesn’t support, how people commonly use it, and who should be cautious.

What Is Magnesium Glycinate?

Magnesium glycinate (also called magnesium bisglycinate) is a compound formed by binding magnesium to glycine, a non-essential amino acid that also acts as an inhibitory neurotransmitter in the central nervous system. This chelated form is generally considered gentler on the digestive system than forms like magnesium oxide or magnesium citrate, which are more likely to cause loose stools, especially at higher doses.

Magnesium itself is an essential mineral involved in more than 300 enzymatic reactions in the body, including energy production, muscle and nerve function, protein synthesis, and regulation of the nervous system. According to the National Institutes of Health Office of Dietary Supplements, a large share of adults in the U.S. do not consume the recommended amount of magnesium from food alone, which is one reason it draws interest as a supplement — not because it’s a cure for anything, but because closing a nutritional gap may support normal physiological function. (Source: NIH Office of Dietary Supplements, Magnesium Fact Sheet for Health Professionals)

Why People Connect Magnesium to Sleep and Relaxation

Magnesium plays a role in regulating neurotransmitters that calm the nervous system, including GABA, and it’s involved in the body’s stress-response pathway (the HPA axis). It also interacts with melatonin regulation and muscle relaxation, both of which are relevant to winding down at night. This is the biological rationale researchers point to when studying magnesium and sleep — but rationale isn’t the same as proof, so it’s worth looking at what’s actually been tested.

What the Research Shows — and Its Limits

The evidence on magnesium and sleep/stress is genuinely promising in places, but it is not the kind of large, ironclad evidence base that would support a medical claim. Here’s an honest summary of some of the more frequently cited studies:

• Magnesium and insomnia in older adults. A randomized, double-blind, placebo-controlled trial published in the Journal of Research in Medical Sciences (Abbasi et al., 2012) gave elderly participants with insomnia 500 mg of magnesium daily for eight weeks. The magnesium group showed improvements in subjective measures of sleep quality, including sleep time and sleep efficiency, compared with placebo. This is one of the more commonly cited human trials, though it was relatively small and specific to an older population, so its results don’t automatically generalize to everyone. (Source: PubMed, Abbasi B et al., “The effect of magnesium supplementation on primary insomnia in elderly,” J Res Med Sci, 2012)
• Magnesium and self-reported stress. A systematic review published in Nutrients (Boyle, Lawton & Dye, 2017) examined the evidence for magnesium supplementation on subjective anxiety and stress. The authors concluded that while some low-quality studies suggested a benefit, particularly in people with pre-existing low magnesium status or elevated stress susceptibility, the overall evidence base was limited by small sample sizes and inconsistent methodology, and they called for larger, better-designed trials. (Source: PubMed, Boyle NB et al., “The Effects of Magnesium Supplementation on Subjective Anxiety and Stress,” Nutrients, 2017)
• Magnesium and stress-related heart rate variability. A study by Wienecke and Nolden (2016) used heart rate variability (HRV) as an objective marker of autonomic nervous system stress and found associations between magnesium intake and reduced physiological stress markers over an extended period. HRV studies like this are interesting because they look at a measurable physiological signal rather than only self-report, but this remains one study, not a settled consensus. (Source: PubMed, Wienecke E, Nolden C., “Langzeit-HRV-Analyse zeigt Stressreduktion durch Magnesium,” MMW Fortschr Med, 2016)

Taken together, this body of research is best described as promising but preliminary. It’s enough to explain why magnesium — and specifically the more bioavailable, gut-friendly glycinate form — has become a popular part of evening wind-down routines. It is not enough to say magnesium glycinate treats insomnia, anxiety, or any diagnosed condition. If you have a sleep disorder or a diagnosed anxiety condition, that’s a conversation for a doctor, not a supplement label.

It’s also worth being transparent about a common industry gap: most of the human trials on magnesium and sleep/stress used generic “magnesium supplementation” rather than the glycinate form specifically. The reasoning for glycinate’s added benefit rests partly on glycine’s own studied role in sleep (glycine alone has been studied for sleep quality in a few small trials) and partly on its superior absorption and tolerability compared to cheaper magnesium salts — not on glycinate-specific sleep trials. We think it’s better to say that plainly than to imply more certainty than the literature currently offers.

Typical Dosing

The NIH lists the Recommended Dietary Allowance (RDA) for magnesium at 400–420 mg/day for adult men and 310–320 mg/day for adult women (elemental magnesium, from all dietary sources combined). Most magnesium glycinate supplements are formulated to provide somewhere in the range of 100–200 mg of elemental magnesium per serving, since the glycine portion of the compound adds bulk without adding elemental magnesium — so always check the “elemental magnesium” amount on the label rather than the total compound weight.

The NIH also sets a Tolerable Upper Intake Level (UL) of 350 mg/day for magnesium from supplements specifically (this UL does not apply to magnesium from food, which the body regulates more easily). Staying within label-recommended serving sizes, and not stacking multiple magnesium-containing products at once, is the simplest way to stay under that threshold. Many people take their dose in the evening, an hour or so before bed, simply because that’s when the calming association is most relevant — though the research doesn’t establish one “correct” time of day.

Who Magnesium Glycinate May Suit

Based on the available evidence and general nutrition guidance, magnesium glycinate tends to be of interest to:

• Adults whose diet is genuinely low in magnesium-rich foods (leafy greens, nuts, seeds, legumes, whole grains)
• People who have tried other forms of magnesium (like oxide or citrate) and experienced digestive discomfort, since glycinate is generally better tolerated
• People looking for an evening wind-down addition alongside good sleep hygiene — consistent sleep schedule, reduced screen time before bed, a cool dark room — rather than as a replacement for those basics
• Adults under everyday stress who want to support normal relaxation processes, understanding this is a “may support” supplement, not a treatment

It’s not a fit for people expecting a fast-acting sedative effect, and it’s not a substitute for medical care if you have a diagnosed sleep or anxiety disorder.

Cautions

Magnesium glycinate is generally well tolerated, but a few things are worth knowing:

• Medication interactions: Magnesium can interact with certain antibiotics (like tetracyclines and quinolones), bisphosphonates, and some diuretics. It should generally be taken a few hours apart from these medications. Talk to a pharmacist or doctor if you’re on regular medication.
• Kidney function: People with impaired kidney function have a reduced ability to excrete excess magnesium and should consult a doctor before supplementing, since magnesium can accumulate to harmful levels.
• Pregnancy and breastfeeding: Talk to a healthcare provider before starting any new supplement during pregnancy or while breastfeeding.
• Digestive effects: While glycinate is gentler than many forms, high doses of any magnesium supplement can still cause loose stools or stomach upset in some people. Starting at a lower dose and adjusting is a reasonable approach.
• Not a substitute for care: Chronic insomnia, persistent anxiety, or ongoing sleep disruption deserve a conversation with a healthcare provider — supplements are, at best, one small piece of a bigger picture.

The Bottom Line

Magnesium glycinate isn’t a miracle sleep aid, and no honest source will tell you it is. What the evidence supports is more modest: magnesium plays a real, well-documented role in nervous system regulation, many adults fall short of getting enough of it from food, and a handful of human trials suggest supplementation may support better subjective sleep quality and lower stress markers in some people — particularly those who are magnesium-insufficient to begin with. The glycinate form is popular mainly because it’s well absorbed and easy on the stomach, making it a practical way to close that gap as part of a broader wind-down routine.

If you want to try it, NutriPeak carries a magnesium glycinate formula dosed to make it easy to stay within recommended daily amounts — worth a look if you’re building out an evening routine and want a well-tolerated way to support normal magnesium intake.

This article is for educational purposes and is not medical advice. Speak with a healthcare provider before starting any new supplement, especially if you take medication or have a health condition.